Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

BLACK DIAMOND THERAPEUTICS, INC. (BDTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

BLACK DIAMOND THERAPEUTICS, INC. (BDTX), most recent 12 months reported: revenue $0, net loss $42.55M. Latest balance sheet on file: liquid cash $110.51M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): ANAVEX LIFE SCIENCES CORP. · BIOATLA, INC. · BioCardia, Inc. · BRAINSTORM CELL THERAPEUTICS INC. · Black Hawk Acquisition Corporation · CABALETTA BIO, INC. · CANDEL THERAPEUTICS, INC. · CERO THERAPEUTICS HOLDINGS, INC.

Stock screener

Watchlist